Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Accepted: 21 July 2025
First Online: 20 August 2025
Competing interests
: Y.R. acts as an adviser for Freya Pharma, Ohhmed Medical and Androlab. He also declares he is a speaker forIBSA, Boston Scientific and Ipsen. A.P. declares speaker honoraria from Novo Nordisk and Dexcel Pharma, and study funding and travel support from Hikkonu and Direx Group, and also serves on the advisory board for Tiki100. A.D. is a medical adviser for Sensera.
